Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin

BACKGROUND: Diabetes increases a patient’s risk of developing atrial fibrillation by 49%. Patients with nonvalvular atrial fibrillation are at a fivefold increased risk of stroke and die more frequently from vascular causes. We sought to evaluate the effectiveness and safety of rivaroxaban versus wa...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cardiovasc Diabetol
Hoofdauteurs: Coleman, Craig I., Costa, Olivia S., Brescia, Christopher W., Vardar, Burcu, Abdelgawwad, Khaled, Sood, Nitesh
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2021
Onderwerpen:
Original Investigation
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7913443/
https://ncbi.nlm.nih.gov/pubmed/33637082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-021-01250-5
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items